SS 43 - Palliative Care in Oncology

Presentations

• 03:45pm - 03:55pm ET

  A Randomized Controlled Trial: Cognitive Behavior Therapy for Anxiety, Depressive Symptoms and Acute Toxicities in Oligometastatic Nasopharyngeal Carcinoma Patients Receiving Anti-PD-1, Chemotherapy and Stereotactic Body Radiation Therapy

  Speaker: Feng Liu, MD - Hunan Cancer Hospital, Changsha
• 03:55pm - 04:05pm ET

  SOAR-HN: A Phase II Randomized Trial of Stereotactic Body Radiotherapy vs. Conventionally Fractionated Reirradiation for Previously Treated, Unresectable Head and Neck Cancer

  Speaker: Liam Spurr, MD - MD Anderson Cancer Center, Houston
• 04:05pm - 04:15pm ET

  Association Between Previous Radiotherapy Response and Pain Response After Palliative Re-Irradiation: Prospective Study

  Speaker: Yutaro Koide, MD, PhD - Aichi Cancer Center Hospital, Nagoya
• 04:15pm - 04:25pm ET

  Dose Escalated Simultaneous Integrated Boost Versus Standard Palliative Radiotherapy for Bone Metastases: A Comparative Analysis

  Speaker: Purvi Rathod, MD - Nanavati Max Superspeciality Hospital, Mumbai
• 04:25pm - 04:35pm ET

  The Role of Stereotactic Body Radiotherapy in Oligoprogressive Breast Cancer: A Site-Specific Analysis of the Prospective, Phase-II RADIANT Trial

  Speaker: Kara Ruicci, MD, PhD - University of Toronto, Toronto
• 04:35pm - 04:45pm ET

  Genomic Signature with Next-Generation Sequencing for Oligometastatic Disease in Breast Cancer

  Speaker: Patrick Young, DO - Atrium Health Wake Forest Baptist, Lexington